Cargando…

Risk of Post-Myocardial Infarction Pneumonia with Proton Pump Inhibitors, H2 Receptor Antagonists and Mucoprotective Agents: A Retrospective Nationwide Cohort Study

Patients with myocardial infarction (MI) are at high risk of developing pneumonia. Proton pump inhibitors (PPI) and H2-receptor antagonists (H2RA) are commonly used acid-suppressive medications to the patients with MI for gastrointestinal (GI) protection, which may increase the risk for pneumonia. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Jimin, Kim, Jinkwon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778571/ https://www.ncbi.nlm.nih.gov/pubmed/35055393 http://dx.doi.org/10.3390/jpm12010078

Ejemplares similares

Risk of post-stroke pneumonia with proton pump inhibitors, H(2) receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study
por: Song, Tae-Jin, et al.
Publicado: (2019)

Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
por: Shah, Nigam H., et al.
Publicado: (2015)

Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
por: Lee, Yong Kang, et al.
Publicado: (2023)

Dipstick proteinuria and risk of type 2 diabetes mellitus: a nationwide population-based cohort study
por: Jeon, Jimin, et al.
Publicado: (2021)

H(2) antagonists, proton pump inhibitors and COVID-19
por: Hirota, Kazuyoshi
Publicado: (2022)

Impact of proton pump inhibitor treatment on gastrointestinal bleeding associated with non-steroidal anti-inflammatory drug use among post-myocardial infarction patients taking antithrombotics: nationwide study
por: Schjerning Olsen, Anne-Marie, et al.
Publicado: (2015)

Mucoprotective effect of ellagic acid in 5 fluorouracil-induced intestinal mucositis model
por: AL-hoshary, Dareen Mahmood, et al.
Publicado: (2023)

Lower risk of subarachnoid haemorrhage in diabetes: a nationwide population-based cohort study
por: Kim, Jang Hoon, et al.
Publicado: (2021)

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Pre-existing Proton Pump Inhibitor Treatment and Short-Term Prognosis of Acute Myocardial Infarction Patients
por: Xie, Juntao, et al.
Publicado: (2022)

Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series
por: Chui, Celine S L, et al.
Publicado: (2022)

Effectiveness of acid suppressants and other mucoprotective agents in reducing the risk of occult gastrointestinal bleeding in nonsteroidal anti-inflammatory drug users
por: Kim, Tae Jun, et al.
Publicado: (2019)

Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study
por: Charlot, Mette, et al.
Publicado: (2011)

Effects of Proton Pump Inhibitors and H(2) Receptor Antagonists on the Ileum Motility
por: Kurt, Atilla, et al.
Publicado: (2011)

Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)

Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study
por: Yoo, Joonsang, et al.
Publicado: (2022)

Corrigendum: Pre-existing proton pump inhibitor treatment and short-term prognosis of acute myocardial infarction patients
por: Xie, Juntao, et al.
Publicado: (2022)

Correction to: Proton pump inhibitors and myocardial infarction: an application of active comparators in a self-controlled case series
Publicado: (2022)

Oral health and longitudinal changes in fasting glucose levels: A nationwide cohort study
por: Song, Tae-Jin, et al.
Publicado: (2021)

Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
por: Yoo, Joonsang, et al.
Publicado: (2023)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Proton pump inhibitors versus H2 antagonists for prevention of COVID-19 complications
por: Kishore, E, et al.
Publicado: (2023)

Proton-pump inhibitors among adults: a nationwide drug-utilization study
por: Hálfdánarson, Óskar Ö., et al.
Publicado: (2018)

The Association between Proton Pump Inhibitors and Myocardial Infarction: What Do Food and Drug Administration Data Tell Us?
por: Tan, Jiun Ming, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden
por: Wang, Yun-Han, et al.
Publicado: (2022)

Association between the fatty liver index and the risk of severe complications in COVID-19 patients: a nationwide retrospective cohort study
por: Chang, Yoonkyung, et al.
Publicado: (2022)

Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma
por: Lee, Yoo-Young, et al.
Publicado: (2015)

Oral Health and Risk of Retinal Vascular Occlusions: A Nationwide Cohort Study
por: Chang, Yoonkyung, et al.
Publicado: (2023)

Impact of proton pump inhibitors on clinical outcomes in patients after acute myocardial infarction: a propensity score analysis from China Acute Myocardial Infarction (CAMI) registry
por: SHI, Wen-Ce, et al.
Publicado: (2020)

Association of proton pump inhibitor and histamine H(2)-receptor antagonists with restless legs syndrome
por: Earley, Eric J, et al.
Publicado: (2020)

Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium
por: Lee, Tsung-Ming, et al.
Publicado: (2018)

Effects of proton pump inhibitor versus H2-receptor antagonist stress ulcer prophylaxis on ventilator-associated pneumonia: a pilot study
por: Fogas, JF, et al.
Publicado: (2013)

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021)

Proton pump inhibitor use and risk of depression and anxiety in children: nationwide cohort study
por: Wang, Yun‐Han, et al.
Publicado: (2022)

Proton pump inhibitor use is associated with hip fracture development: a nationwide population-based cohort study
por: Min, Yang Won, et al.
Publicado: (2020)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Off-Pump Repair of a Post Myocardial Infarction Ventricular Septal Defect
por: Sabzi, Feridoun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k437jop1qh6v989ep9ajuhgb4d